Modern History of Cholera Vaccines and the Pivotal Role of icddr,b.
cholera vaccine
mucosal immunity
pandemic
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
20 12 2021
20 12 2021
Historique:
pubmed:
29
8
2021
medline:
27
1
2022
entrez:
28
8
2021
Statut:
ppublish
Résumé
The rapid spread of the seventh cholera pandemic over Asia in the 1960s led to several large field studies that revealed that the traditional injectable cholera vaccines had poor efficacy, which led the World Health Organization (WHO) in the 1970s to stop recommending cholera vaccination. At the same time, it stimulated research that has led to the development of the effective orally administered cholera vaccines (OCVs) that today are a cornerstone in WHO's strategy for Ending Cholera-A Global Roadmap to 2030. The first effective OCV, Dukoral, containing a mixture of inactivated Vibrio cholerae bacteria and cholera toxin B subunit, was licensed in 1991 and is, together with 2 similar inactivated whole-cell OCVs, Shanchol and Euvichol, currently WHO prequalified and recommended OCVs. This brief review is a personal account of the modern history of the development of these now universally recognized effective tools.
Identifiants
pubmed: 34453544
pii: 6359024
doi: 10.1093/infdis/jiab423
pmc: PMC8687080
doi:
Substances chimiques
Cholera Vaccines
0
Vaccines, Inactivated
0
Types de publication
Historical Article
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S742-S748Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
Prog Allergy. 1983;33:106-19
pubmed: 6338509
Lancet. 2009 Nov 14;374(9702):1694-702
pubmed: 19819004
Vaccine. 1996 Oct;14(15):1459-65
pubmed: 8994322
Infect Immun. 1973 Aug;8(2):208-14
pubmed: 4125267
Nature. 1977 Oct 13;269(5629):602-4
pubmed: 72361
Infect Immun. 1976 Mar;13(3):735-40
pubmed: 1270131
J Gen Microbiol. 1973 Jun;76(2):417-27
pubmed: 4198716
Trop Med Infect Dis. 2021 Apr 28;6(2):
pubmed: 33925118
Lancet. 2017 Sep 23;390(10101):1539-1549
pubmed: 28302312
Vaccine. 2006 May 15;24(20):4297-303
pubmed: 16580760
Lancet. 1994 Nov 5;344(8932):1273-6
pubmed: 7967990
Eur J Biochem. 1981 Jan;113(2):249-58
pubmed: 6258916
Lancet. 1988 Jun 18;1(8599):1375-9
pubmed: 2898052
Lancet. 2005 Jul 2-8;366(9479):44-9
pubmed: 15993232
Vaccine. 2020 Feb 29;38 Suppl 1:A118-A126
pubmed: 31879125
Vaccine. 2007 Jan 22;25(6):1149-55
pubmed: 17055622
J Infect Dis. 1988 Aug;158(2):372-7
pubmed: 3042876
Biochemistry. 1973 Aug 28;12(18):3558-66
pubmed: 4731192
J Infect Dis. 1984 Jun;149(6):884-93
pubmed: 6736680
Lancet. 1997 Jan 25;349(9047):231-5
pubmed: 9014909
Clin Infect Dis. 2013 Apr;56(8):1123-31
pubmed: 23362293
Lancet. 1986 Jul 19;2(8499):124-7
pubmed: 2873397
Science. 1974 Feb 15;183(4125):656-7
pubmed: 4810267
Vaccine. 2018 Oct 29;36(45):6606-6614
pubmed: 30314912
Lancet. 1990 Feb 3;335(8684):270-3
pubmed: 1967730
Proc Natl Acad Sci U S A. 1989 Jan;86(2):481-5
pubmed: 2492108
Expert Rev Vaccines. 2017 Mar;16(3):197-213
pubmed: 28165831
Lancet Infect Dis. 2012 Nov;12(11):837-44
pubmed: 22954655
J Clin Invest. 1972 Apr;51(4):796-804
pubmed: 4335444
Infect Immun. 1987 May;55(5):1116-20
pubmed: 3552989
Nature. 1981 Jul 30;292(5822):413-17
pubmed: 7019725